Paratus Sciences - Crunchbase Company Profile & Funding

Q: Who invested in Paratus Sciences?

Paratus Sciences has 6 investors including EcoR1 Capital And ClavystBio.

Q: When was the last funding round for Paratus Sciences?

Paratus Sciences closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Paratus Sciences raised to date?

Paratus Sciences has raised obfuscated.

Overview

Paratus Sciences

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Paratus Sciences

CB Rank

36421

Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.

Founded

obfuscation

Private

Series A

New York, New York, United States

11-50

www.paratussciences.com/

Biotechnology

Health Care

Funding Rounds

Series A

OBF

obfuscation

Key People

Thomas Zwaka: Founder
Paul Matsudaira: Co-Founder, former interim CSO

Details

Legal Name

Paratus Sciences Corporation

Operating Status

Active

Company Type

For Profit

Founders

Paul Matsudaira, Richard Young, Thomas Zwaka

About the Company

Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Integrated Discovery Platform

A platform that combines genomics and informatics to analyze bat DNA and identify therapeutic targets for human diseases.

Therapeutic Target Discovery Pipeline

A process to identify and validate novel drug targets inspired by bats’ adaptations to treat immunological, inflammatory, and cardiometabolic diseases.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Paratus Sciences	6	obfuscated obfuscation	ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Polaris Partners	Series A
obfuscated obfuscation	Series A - Paratus Sciences	6	obfuscated obfuscation	ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Polaris Partners	Series A
obfuscated obfuscation	Series A - Paratus Sciences	6	obfuscated obfuscation	ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Polaris Partners	Series A
obfuscated obfuscation	Series A - Paratus Sciences	6	obfuscated obfuscation	ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Polaris Partners	Series A
obfuscated obfuscation	Series A - Paratus Sciences	6	obfuscated obfuscation	ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Polaris Partners	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Paratus Sciences	6	obfuscated obfuscation	ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Polaris Partners	Series A
obfuscated obfuscation	Series A - Paratus Sciences	6	obfuscated obfuscation	ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Polaris Partners	Series A
obfuscated obfuscation	Series A - Paratus Sciences	6	obfuscated obfuscation	ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Polaris Partners	Series A
obfuscated obfuscation	Series A - Paratus Sciences	6	obfuscated obfuscation	ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Polaris Partners	Series A
obfuscated obfuscation	Series A - Paratus Sciences	6	obfuscated obfuscation	ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Polaris Partners	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
EcoR1 Capital	Yes	Series A - Paratus Sciences	—
EcoR1 Capital	Yes	Series A - Paratus Sciences	—
EcoR1 Capital	Yes	Series A - Paratus Sciences	—
EcoR1 Capital	Yes	Series A - Paratus Sciences	—
EcoR1 Capital	Yes	Series A - Paratus Sciences	—